Evaluation of Diet and Sleep in Vascular Health: A Pilot Study
- Conditions
- Sleep
- Interventions
- Behavioral: Average American Diet (AAD)Behavioral: Mediterranean Diet
- Registration Number
- NCT04990973
- Lead Sponsor
- Columbia University
- Brief Summary
The goal of this study is to test the impact of diet on sleep and cardiovascular disease risk factors.
- Detailed Description
Poor sleep quality is highly prevalent in adults in the U.S. and worldwide. Recent work suggests that dietary intakes may influence sleep. This mechanistic study will test whether consuming a healthy, Mediterranean diet will improve sleep quality in U.S. adults with poor sleep and lead to better cardiovascular disease risk profile. Given the relationship between sleep and cardiovascular health, improving sleep quality through dietary measures could contribute to improving health in adults.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 11
- Sleep >6 hours/night
- Sleep complaints
- Smoking
- Allergies to foods
- Inability to comply with study procedures
- Gastrointestinal disorders
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Mediterranean Diet and then AAD Mediterranean Diet Healthy participants that are randomized to the MedDiet followed by a 4-week washout and a crossover to the AAD. Mediterranean Diet and then AAD Average American Diet (AAD) Healthy participants that are randomized to the MedDiet followed by a 4-week washout and a crossover to the AAD. Average American Diet (AAD) and then Mediterranean Diet Mediterranean Diet Healthy participants that are randomized to AAD followed by a 4-week washout and a crossover to the Mediterranean Diet. Average American Diet (AAD) and then Mediterranean Diet Average American Diet (AAD) Healthy participants that are randomized to AAD followed by a 4-week washout and a crossover to the Mediterranean Diet.
- Primary Outcome Measures
Name Time Method Score on the Pittsburgh Sleep Quality Index (PSQI) 4 weeks The 19 questions which compose this survey assess sleep quality, latency, duration, habitual sleep efficiency, sleep disturbances, medication use and daytime dysfunction. Scores range 0 (minimum) to 21 (maximum) with \>5 indicating poor sleep quality so a lower score is a better outcome.
Sleep Fragmentation Index 4 weeks Sleep Fragmentation is an index of restlessness during the sleep period expressed as a percentage (0 to 100%). The higher the index, the more sleep is disrupted.
Average Sleep Duration Per Night 4 weeks Sleep duration will be actigraphy-derived.
- Secondary Outcome Measures
Name Time Method Change in Urinary 6-sulfatoxymelatonin Level Change from baseline to 4 weeks Urinary 6-sulfatoxymelatonin will be measured by competitive ELISA and urine creatinine by clinical chemistry analyzer.
Change in Tryptophan Change from baseline to 4 weeks Tryptophan metabolism
Change in Kynurenine Change from baseline to 4 weeks Tryptophan metabolism
Change in Serotonin Change from baseline to 4 weeks Neurotransmitter
Trial Locations
- Locations (1)
Columbia University Irving Medical Center
🇺🇸New York, New York, United States